Global Varicose Vein Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In September 2023, VVT Medical secured FDA clearance for its ScleroSafe chemical ablation platform, enabling non‑thermal, single-hand treatment of superficial varicose veins with advanced efficiency.

• In April 2023, Theraclion obtained FDA IDE approval for its pivotal VEINRESET study using the Sonovein HIFU system, aiming to non-invasively treat great saphenous varicose veins at leading U.S. centers.

In this report, the Varicose Vein Treatment Market has been segmented by Type, Procedure, End User and Geography.

Varicose Vein Treatment Market, Segmentation by Type

The Varicose Vein Treatment Market has been segmented by Type into Sclerotherapy and Endovenous Ablation [Radio Frequency Ablation and Laser Ablation], Stripping

Sclerotherapy

Sclerotherapy is a non-invasive treatment involving the injection of a solution into varicose veins to cause their closure. This method represents nearly 30% of treatments due to its simplicity, low recovery time, and widespread availability.

Endovenous Ablation

Endovenous ablation is a minimally invasive procedure using thermal energy to treat veins. It includes radio frequency ablation (RFA) and laser ablation (EVLA), together comprising around 50% of the market due to their high success rate and minimal discomfort.

Stripping

Stripping is a traditional surgical method that involves the removal of varicose veins. Though used less frequently today, it still holds about 20% market share, mainly in areas with limited access to advanced procedures.

Varicose Vein Treatment Market, Segmentation by Procedure

The Varicose Vein Treatment Market has been segmented by Procedure into Injection Sclerotherapy, and Surgical Ligation/Stripping.

Injection Sclerotherapy

Injection sclerotherapy commands the largest share at around 46%, valued for its non-invasive nature and cost advantages. It effectively treats small to moderate varicose veins, allowing patients to resume daily activities quickly.

Surgical Ligation/Stripping

Surgical ligation and stripping hold approximately 15% of the market and remain crucial for severe varicose vein cases. Though more invasive, these procedures ensure comprehensive vein removal and durable results.

Varicose Vein Treatment Market, Segmentation by End User

The Varicose Vein Treatment Market has been segmented by End User into Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), and Others.

Hospitals

Accounting for approximately 45% of the market, hospitals are the primary providers of varicose vein treatments due to their advanced infrastructure and capacity to handle complex cases. They offer a broad range of treatment options, including surgical and minimally invasive procedures.

Specialty Clinics

Specialty clinics hold about 30% share, emphasizing targeted vein care with expert staff and state-of-the-art technologies. Their focus on patient-centric, minimally invasive treatments drives their growing popularity.

Ambulatory Surgical Centers (ASCs)

ASCs comprise nearly 20% of the market, valued for their cost-effective outpatient services and efficient patient throughput. These centers are increasingly preferred for procedures like endovenous ablation and sclerotherapy.

Others

Representing around 5%, the "Others" category includes smaller healthcare facilities and office-based practices that provide accessible vein care, particularly in underserved or rural areas.

Varicose Vein Treatment Market, Segmentation by Geography

In this report, the Varicose Vein Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Varicose Vein Treatment Market Share (%), by Geographical Region

North America

Holding approximately 40% of the market, North America leads due to its sophisticated healthcare infrastructure and widespread use of advanced varicose vein treatments such as endovenous ablation. High patient demand for effective and cosmetic therapies further boosts market growth.

Europe

Europe accounts for about 30% of the market, supported by mature healthcare services and strong governmental focus on vascular health. The preference for minimally invasive outpatient procedures is particularly prominent in Western Europe.

Asia Pacific

Asia Pacific commands close to 20% market share, driven by increasing urban populations and healthcare investments. Countries like China and India are witnessing rising acceptance of varicose vein treatments due to awareness and improved medical facilities.

Middle East and Africa

Comprising nearly 6% of the market, the Middle East and Africa are gradually growing through enhanced healthcare access and the adoption of minimally invasive therapies, although infrastructural limitations persist in some areas.

Latin America

Latin America holds about 4% of the market. Rising awareness, better healthcare infrastructure, and economic growth in countries such as Brazil and Mexico are key factors driving market expansion.

This report provides an in depth analysis of various factors that impact the dynamics of Varicose Vein Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Rising prevalence of varicose veins and chronic venous insufficiency
• Growing awareness and patient preference
• Expansion of ambulatory surgical centers (ASCs)

• Shift toward minimally invasive treatments - The growing shift toward minimally invasive treatments is a key driver of the Varicose Vein Treatment Market. Patients are increasingly opting for procedures that offer reduced pain, shorter recovery times, and lower risks compared to traditional surgical methods. Treatments such as endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and sclerotherapy are gaining popularity due to their effectiveness and outpatient nature. These methods are not only less invasive but also offer aesthetically pleasing outcomes, which is especially important for patients concerned about the appearance of varicose veins.

  This trend is further supported by advancements in medical technology and imaging techniques that enable greater precision during procedures. Healthcare providers are also favoring minimally invasive techniques as they allow for quicker patient turnover, fewer complications, and reduced healthcare costs. As the demand for patient-friendly treatment options continues to rise, the adoption of minimally invasive procedures is expected to accelerate, significantly contributing to the growth and evolution of the varicose vein treatment landscape.

Restraints

• Limited access to advanced treatment facilities
• Dearth of trained vascular surgeons and specialists
• Inconsistent reimbursement policies and insurance coverage

• Risks of procedure-related complications - Risks of procedure-related complications remain a significant restraint in the Varicose Vein Treatment Market, despite the increasing adoption of minimally invasive techniques. Although treatments such as laser ablation, sclerotherapy, and radiofrequency ablation are generally considered safe, they are not without potential side effects. Patients may experience complications such as bruising, pain, nerve damage, blood clots, or skin discoloration, which can impact recovery and deter individuals from pursuing treatment. These risks contribute to a level of apprehension among patients, especially those with underlying health conditions or a history of poor wound healing.
  
  Healthcare providers must also weigh these risks when recommending treatment plans, which can sometimes delay or limit access to advanced therapies. Additionally, legal and ethical concerns tied to procedure outcomes may discourage smaller clinics and practitioners from offering certain treatments. The presence of these procedural risks highlights the need for improved techniques, better patient screening, and thorough post-operative care protocols. Until these concerns are adequately addressed, they are likely to hinder the full growth potential of the varicose vein treatment market.

Opportunities

• Rising prevalence of varicose veins
• Increasing healthcare spending and favorable reimbursement policies
• Growth in medical tourism

• Shift toward minimally invasive procedures - The growing shift toward minimally invasive procedures presents a significant opportunity in the Varicose Vein Treatment Market. Patients are increasingly favoring treatment options that offer faster recovery, reduced pain, and minimal scarring compared to traditional surgical interventions. Procedures such as endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and foam sclerotherapy are becoming the preferred choices due to their outpatient nature and high success rates. These methods not only improve patient comfort and satisfaction but also enhance procedural efficiency for healthcare providers, making them a valuable option in both clinical and cosmetic settings.

  Advancements in medical devices and imaging technologies have further fueled this trend by enabling more precise, safer, and less invasive interventions. As awareness about these procedures grows, especially among the aging population and working professionals seeking effective but convenient treatment, demand is expected to rise substantially. Healthcare systems are also benefiting from reduced hospitalization costs and lower complication rates associated with minimally invasive techniques. This evolving preference is opening new avenues for innovation, investment, and market penetration, positioning minimally invasive procedures as a key growth engine for the varicose vein treatment industry.

Key players in Varicose Vein Treatment Market include:

• Medtronic plc
• AngioDynamics Inc
• Biolitec AG
• Lumenis Ltd
• Syneron Medical Ltd
• Dornier MedTech GmbH
• Alma Lasers Ltd
• Vascular Solutions Inc
• BTG plc
• AngioTech Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Market Share Analysis
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis